Immunomodulatory drugs may overcome the negative prognostic role of active Th17 axis in follicular lymphoma: evidence from the SAKK35/10 trial

Lymphoma
11/06/2020

Menter T, et al. Br J Haematol 2020.

NO ABSTRACT